Advanced prostate cancer detection AI which
enhances accuracy and efficiency in pathology workflows.
Predictions indicate that the number of new cases of prostate cancer will reach 2.9 million by 2040 (107% increase from 1.4 million in 2020)*.
With pathologists responsible for diagnosing 100% of all cancers, their workloads are set to increase significantly, particularly for prostate cancer cases.
*Global prostate cancer statistics 2024: Lancet Commission projections of incidence and mortality worldwide
Franklin.ai harnesses state-of-the-art artificial intelligence to revolutionise AI Prostate Cancer Detection. Our advanced AI models analyse both physical pathology slides and digital pathology scans with precision, assisting pathologists in identifying clinically significant abnormalities that may indicate prostate cancer. By streamlining routine diagnostic tasks and highlighting areas of concern, our technology helps pathologists manage increasing workloads effectively. This ensures faster reporting and detection without compromising accuracy, enabling pathologists to focus their expertise where it’s needed most. With the rising number of prostate cancer cases, Franklin.ai is committed to supporting pathologists in delivering timely and reliable diagnoses for better patient outcomes.
Franklin.ai’s solutions are tailored to meet the needs of both traditional and modern pathology workflows. Franklin.ai Digital pre-analyses cases with advanced AI, flagging the most severe specimens for immediate attention. Findings are accurately localised and seamlessly pre-populated into synoptic and microscopic reports, saving valuable time and allowing pathologists to prioritise their expertise on complex cases. This digital solution enhances efficiency and accuracy, reducing administrative burdens while enabling faster, more confident diagnoses.
For laboratories using traditional glass slides, Franklin.ai Glass delivers the power of AI without the need for costly digital scanners. By providing real-time feedback directly from glass slide samples, this standalone solution supports pathologists with a second set of eyes, detecting clinically relevant findings and prognostic factors for prostate core biopsies. It also generates high-quality digital images that facilitate collaboration during multidisciplinary team meetings, research, and teaching, ensuring pathologists can adopt AI technology regardless of their existing infrastructure.
Our AI technology excels in detecting clinically significant findings in prostate core biopsies and TURP chips, revolutionising AI Prostate Cancer Detection. By automating repetitive tasks such as identifying areas of interest and quantifying findings, it enhances the accuracy of initial assessments. This allows pathologists to focus their expertise on complex diagnostic decisions while streamlining workflows and reducing administrative burdens.
Detecting prostate cancer with accuracy is crucial for patient outcomes. Franklin.ai’s AI Prostate Cancer Detection tools assist pathologists by highlighting malignancies and grading cancer severity with precision, ensuring they have reliable support for every diagnosis.
By automating repetitive tasks and providing detailed insights, our AI enhances diagnostic accuracy and consistency, enabling pathologists to focus on complex decision-making with greater confidence. This seamless integration into pathology workflows ensures that each case is approached with the utmost precision and care, even as workloads increase.
Franklin.ai empowers pathologists to deliver accurate, timely, and confident prostate cancer diagnoses.
Franklin.ai is designed to integrate seamlessly into workflows for AI Prostate Cancer Detection, supporting pathologists in routine screenings and providing detailed analyses for complex cases. By combining advanced AI technology with practical functionality, our solutions help laboratories enhance reporting capabilities, improve turnaround times, and maintain high diagnostic accuracy in prostate cancer diagnostics.
Franklin.ai empowers pathologists to deliver precise, reliable results while adapting to the growing demands of prostate cancer diagnostics.
Schedule a call with our team to discover how Franklin.ai can transform your lab’s workflow. Lab directors can enhance efficiency, and pathologists can access advanced support for prostate cancer diagnostics.